Edgewise Therapeutics, Inc. · NASDAQ:EWTX

Novo Holdings A/S reported a 4.90% stake in Edgewise Therapeutics, Inc. (Schedule 13D/A)

Event Apr 23, 2026 · Filed Apr 27, 2026

Novo Holdings A/S reported a 4.90% stake in Edgewise Therapeutics, Inc., 5,350,000 shares, with active intent on Apr 23, 2026. Filed Apr 27, 2026 (Schedule 13D/A).

Stake
4.90%
Shares
5,350,000
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Novo Holdings A/S4.90%5,350,000

Source

View original at SEC

Related